Insider Transactions in Q1 2025 at Castle Biosciences Inc (CSTL)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 20
2025
|
Frank Stokes Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
8,046
-18.55%
|
$209,196
$26.7 P/Share
|
|
Feb 05
2025
|
Daniel Bradbury Director |
SELL
Open market or private sale
|
Indirect |
7,867
-100.0%
|
$220,276
$28.17 P/Share
|
|
Jan 13
2025
|
Derek J Maetzold Pres. & Chief Exec. Officer |
SELL
Open market or private sale
|
Indirect |
1,579
-0.72%
|
$44,212
$28.55 P/Share
|
|
Jan 13
2025
|
Derek J Maetzold Pres. & Chief Exec. Officer |
SELL
Open market or private sale
|
Direct |
986
-0.4%
|
$27,608
$28.55 P/Share
|
|
Jan 07
2025
|
Derek J Maetzold Pres. & Chief Exec. Officer |
SELL
Open market or private sale
|
Indirect |
388
-0.52%
|
$11,640
$30.14 P/Share
|
|
Jan 07
2025
|
Derek J Maetzold Pres. & Chief Exec. Officer |
SELL
Open market or private sale
|
Direct |
243
-0.3%
|
$7,290
$30.14 P/Share
|
|
Jan 06
2025
|
Daniel Bradbury Director |
SELL
Open market or private sale
|
Indirect |
7,867
-19.77%
|
$228,143
$29.21 P/Share
|
|
Jan 06
2025
|
Tobin W Juvenal Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
2,230
-3.09%
|
$66,900
$30.0 P/Share
|
|
Jan 06
2025
|
Derek J Maetzold Pres. & Chief Exec. Officer |
SELL
Open market or private sale
|
Indirect |
4,343
-1.86%
|
$125,947
$29.24 P/Share
|
|
Jan 06
2025
|
Derek J Maetzold Pres. & Chief Exec. Officer |
SELL
Open market or private sale
|
Direct |
2,715
-1.08%
|
$78,735
$29.24 P/Share
|